Chronic Musculoskeletal Pain
Conditions
Brief summary
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
Interventions
DEVICEPRIMA
Sponsors
PharmaNet
Fralex Therapeutics
Eligibility
Outcome results
None listed